Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_assertion type Assertion NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_head.
- NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_assertion description "[36 (82%) of the patients with BCR-ABL1-like disease had deletions in genes involved in B-cell development, including IKZF1, TCF3, EBF1, PAX5, and VPREB1; only nine (36%) of 25 patients with B-other ALL had deletions in these genes (p=0.0002).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_provenance.
- NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_assertion evidence source_evidence_literature NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_provenance.
- NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_assertion SIO_000772 19138562 NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_provenance.
- NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_assertion wasDerivedFrom befree-20140225 NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_provenance.
- NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_assertion wasGeneratedBy ECO_0000203 NP756183.RAx-lKq-Qtql58HF6_oiK0KyFpyM8ul4GG2GTMphFQrl8130_provenance.